Cytokeratin-positive interstitial reticulum cell tumor: recognition of a potential "in situ" pattern

Hans Bösmüller1, Julia Klenske2, Irina Bonzheim1

  • 1Department of Pathology, University Hospital of Tübingen, D-72076 Tübingen, Germany.

Human Pathology
|January 31, 2016
PubMed

Insights

A rare Cytokeratin-positive interstitial reticulum cell (CIRC) tumor was identified in a patient with endometrial carcinoma. This accessory cell neoplasm presented as a noninvasive, circumscribed lesion in a pelvic lymph node.

Area of Science:

  • Oncology
  • Pathology
  • Immunohistochemistry

Background:

  • Cytokeratin-positive interstitial reticulum cell (CIRC) tumors are rare neoplasms derived from fibroblastic reticulum cells, originating from mesenchymal stem cells.
  • These tumors are accessory cell neoplasms of lymphoid organs.

Observation:

  • A case of CIRC tumor was described in a 67-year-old woman undergoing surgery for endometrial carcinoma.
  • The tumor presented as neoplastic infiltrates in a pelvic lymph node, characterized by large cells with nuclear atypia, atypical mitoses, and apoptosis in a reticular pattern.
  • The infiltrate was circumscribed and located in perifollicular and interfollicular areas without disrupting the lymph node architecture.

Findings:

  • Immunohistochemical analysis revealed coexpression of cytokeratin and vimentin, with partial expression of CD68, CD163, and lysozyme.
  • The neoplastic cells lacked markers of endometrial carcinoma, supporting the diagnosis of CIRC tumor.
  • Immunostains indicated a circumscribed and noninvasive growth pattern, suggesting an early stage of CIRC tumor development.

Implications:

  • This case highlights the importance of accurate diagnosis of rare neoplasms like CIRC tumors, especially in patients with other malignancies.
  • The findings suggest that CIRC tumors may have an "in situ" or early noninvasive stage.
  • Further research into the pathogenesis and behavior of CIRC tumors is warranted.